Two positive phase III studies of tafenoquine for the radical cure of Plasmodium vivax malaria published in The New England Journal of Medicine
MMV Board Member recognized for services to science
Our 17th Call for proposals in now open!
US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria
Doing research on malaria or NTDs? Request the Pathogen Box, free of charge.